Dr. Reddy's buys UCB's India established products business

Dr. Reddy%27s Laboratories Ltd. (NYSE:RDY) acquired the established dermatology, respiratory and pediatrics business in India of UCB Group (Euronext:UCB) for Rs8 billion ($128 million). Combined sales of drugs in the portfolio were Rs1.5 billion ($24 million) in 2014.

UCB said the sale allows it to focus on its neurology portfolio in India. ...